The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
Dealbreaker on MSN
Presbyopia eye drop from startup Tenpoint gets FDA approval, paving way for $235M financing
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
Tenpoint Therapeutics’ Yuvezzi gets US FDA nod; the first and only combo eye drop approved to treat presbyopia: London Saturday, January 31, 2026, 14:00 Hrs [IST] Tenpoint Thera ...
MedPage Today on MSN
FDA OKs More Eye Drops That Can Replace Reading Glasses
Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results